Clinical trial
Genetisk Studie av Amyotrofisk Lateral Sklerose (ALS)
NCT05119387 is registered in ClinicalTrials.gov with Sykehuset Telemark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetisk Studie av Amyotrofisk Lateral Sklerose (ALS)
- Lead sponsor
- Sykehuset Telemark
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 1, 2019
- Completion date
- December 31, 2035
- Enrollment
- 1,200 (estimated)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.